Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P770: Can we predict mucosal inflammation in children with inflammatory bowel disease without colonoscopy?ECCO '18 Vienna
Year: 2018
Authors:

M. Meglicka*, M. Szczepanski, M. Dadalski, J. Kierkus

The Children's Memorial Health Institute, Department of Gastroenterology, Hepatology, Feeding Disorders and Paediatrics, Warsaw, Poland

P771: Diagnostic performance of low haemoglobin density (LHD%) for detecting iron deficiency in patients with inflammatory bowel diseaseECCO '18 Vienna
Year: 2018
Authors:

K. Farrag1,2*, K. Ademaj1,2, E. Leventi1,2, A. Aksan2,3, J. Stein1,2

1DGD Clinics Sachsenhausen, Frankfurt/Main, Germany, 2Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 3Hacettepe University, Faculty of Health Sciences, Ankara, Turkey

P772: Factors influencing adherence to oral 5-aminosalicylic acid in patients with ulcerative colitisECCO '18 Vienna
Year: 2018
Authors:

S.M. Lee1*, T.O. Kim2, J. Lee2, H.W. Kim3, S.R. Ji4

1Dongnam Institute of Radiological and Medical Sciences, Department of Internal Medicine, Busan, South Korea, 2Inje University Haeundae Paik Hospital, Department of Internal Medicine, Busan, South Korea, 3Pusan National University Yangsan Hospital, Department of Gastroenterology, Busan, South Korea, 4Inje University Busan Paik Hospital, Department of Internal Medicine, Busan, South Korea

P773: Rescue treatment with tacrolimus in patients with severe inflammatory bowel disease (IBD) without response to intensification of biological therapyECCO '18 Vienna
Year: 2018
Authors:

L. Sanchis*, X. Cortés, J. Clofent, J. Rodriguez, J.R. Molés, S. Fernández, J. Borrás

Hospital of Sagunto, Valencia, Spain

P774: Comparison of disease burden of ulcerative colitis patients treated with biologics/biosimilars in remission and not in remission across the EU5ECCO '18 Vienna
Year: 2018
Authors:

Y. Lu1*, A. Baskett2, H. Triggs2, B. Haven2, P. Collins2

1Ipsos Healthcare, Therapy Monitors, New York City, USA, 2Ipsos Healthcare, Therapy Monitors, London, UK

P775: Usefulness of endoscopic balloon dilation for colorectal strictures in patients with Crohn’s disease who underwent administration of TNF-α inhibitorECCO '18 Vienna
Year: 2018
Authors:

T. Takeda1*, F. Hirai1, S. Ishikawa2, Y. Yano2, K. Masahiro2, Y. Takada2, T. Beppu2, K. Yao3, T. Matsui2, T. Ueki2

1Fukuoka University Chikushi Hospital, IBD center, Chikushino-shi, Japan, 2Fukuoka University Chikushi Hospital, Gastroenterology, Chikushino-shi, Japan, 3Fukuoka University Chikushi Hospital, Endoscopy, Chikushino-shi, Japan

P776: Ferric carboxymaltose therapy in IBD patients with iron deficient anaemia: Real-life data from GermanyECCO '18 Vienna
Year: 2018
Authors:

J. Stein1,2*, S. Vollmer3, W. Klemm4, K. Nip5, S. Weber-Mangal5, A. Dignass1,6

1Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 2DGD Clinics Sachsenhausen, Frankfurt/Main, Germany, 3Gastroenterological practice, Göppingen, Germany, 4Gastroenterological practice, Cottbus, Germany, 5Vifor Pharma Deutschland GmbH, Munich, Germany, 6Agaplesion Markus Krankenhaus, Frankfurt/Main, Germany

P777: Comparison of costs of different biologic therapies after dose optimisationECCO '18 Vienna
Year: 2018
Authors:

V. Borzan1,2, V. Orsic Fric1,2*, B. Borzan2

1Clinical Hospital Centre Osijek, Department of Gastroenterology and Hepatology, Osijek, Croatia, 2University J.J. Strossmayer of Osijek, Faculty of Medicine, Osijek, Croatia

P778: Real-world drug treatment costs for ulcerative colitis and Crohn’s disease patients treated with vedolizumab vs. anti-TNFα: Results from a German retrospective chart review studyECCO '18 Vienna
Year: 2018
Authors:

S. Campbell-Hill1*, D. Stein2, M. Soni2, C. Coombs3, B. Ratsch4, J.M. Khalid1, K. Minda5

1Takeda Development Centre Europe Ltd., Evidence and Value Generation, London, UK, 2Evidera, London, UK, 3Evidera, Bethesda, MD, USA, 4Takeda Pharma Vertrieb GmbH & Co. KG, Market Access and Public Affairs, Berlin, Germany, 5Takeda Pharmaceuticals International AG, Zurich, Switzerland

P779: Clinical outcome with biological therapy in ulcerative colitis: Real-world clinical setting from a multi-centre observational studyECCO '18 Vienna
Year: 2018
Authors:

L. Ramos1*, A. Hernandez Camba1, R. De La Barreda1, M. Vela2, I. Alonso-Abreu1, R. Gloria Esther2, M. Carrillo-Palau1, C. Tardillo2, Y. Rodríguez2, A. Figueroa Marrero3, D. Ceballos3, N. Cruz4, L. Kolle Casso5, A. Jiménez6, E. Quintero Carrión1,7

1Hospital Universitario de Canarias, Gastroenterology, La Laguna, Spain, 2Hospital Universitario Nuestra Señora de Candelaria, Gastroenterology, Santa Cruz de Tenerife, Spain, 3Hospital Universitario Dr. Negrín Gran Canaria, Gastroenterology, Las Palmas de Gran Canaria, Spain, 4Hospital José Molina Orosa Lanzarote, Gastroenterology, Arrecife, Spain, 5Hospital General de La Palma, Gastroenterology, Santa Cruz de La Palma, Spain, 6Hospital Universitario de Canarias, Research Unit, La Laguna, Spain, 7Universidad de La Laguna, La Laguna, Spain

P780: Interchangeability by a biosimilar of infliximab: What do patients think?ECCO '18 Vienna
Year: 2018
Authors:

M. Baudrant1*, A. Roche1, B. Allenet1, L. Grange2, L. Bouillet3, N. Mathieu4, B. Bonaz4

1CHU Grenoble Alpes, Pharmacy, Grenoble, France, 2CHU Grenoble Alpes, Rhumatologie, Grenoble, France, 3CHU Grenoble Alpes, Médecine Interne, Grenoble, France, 4CHU Grenoble Alpes, Hépatogastroentérologie, Grenoble, France

P781: Biological treatment and surgery in IBD patients stratified by age groupsECCO '18 Vienna
Year: 2018
Authors:

S. Svatun Lirhus1*, M. Ekmark2, B. Saeboe2, B. Moum3, H.O. Melberg4,5

1The University of Oslo, Department of Health Management and Health Economics, Oslo, Norway, 2Takeda Pharmaceuticals, Asker, Norway, 3Oslo University Hospital, Department of Gastroenterology, Oslo, Norway, 4Universitetet i Oslo, Department of Health Management and Health Economics, Oslo, Norway, 5Oslo University Hospital, OCBE, Oslo, Norway

P782: Natural history of acute severe ulcerative colitis in elderly: A population-based studyECCO '18 Vienna
Year: 2018
Authors:

L. Bril1*, A. Leroyer2, M. Fumery3, C. Charpentier1, B. Pariente2, H. Sarter2, D. Laharie4, C. Gower-rousseau2, G. Savoye1

1CHU Charles Nicolle, Gastroenterology, Rouen, France, 2CHU Lille, Gastroenterology, Lille, France, 3CHU Amiens, Gastroenterology, Amiens, France, 4CHU Bordeaux, Gastroenterology, Bordeaux, France

P783: Increased risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide population-based studyECCO '18 Vienna
Year: 2018
Authors:

E.A. Kang1*, J. Lee1, K. Han2, J. Kim1, J. Chun1, J.S. Kim1, J.P. Im1

1Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, South Korea, 2College of Medicine, Catholic University of Korea, Department of Medical Statistics, Seoul, South Korea

P784: The direct healthcare costs of Crohn’s disease increased over the last two decades in a Dutch population-based cohortECCO '18 Vienna
Year: 2018
Authors:

R. Lalisang1*, D. Wintjens1,2, M. Romberg-Camps3, A. van Bodegraven3, L. Oostenbrug3, J. Haans1, A. Masclee1,2, D. Jonkers1,2, M. Pierik1,2

1Maastricht University Medical Centre +, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht, The Netherlands, 2Maastricht University Medical Centre +, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands, 3Zuyderland Medical Centre, Department of Gastroenterology and Hepatology, Sittard-Geleen/Heerlen, The Netherlands

P785: Designing the first pan-European paediatric IBD database to allow the study of incidence and prevalence of UC, CD, and their rare and severe complicationsECCO '18 Vienna
Year: 2018
Authors:

P. Kemos1*, M. Aardoom2, F. Ruemmele3, L. de Ridder2, N. Croft1, on behalf of the PIBD SETQuality consortium and PIBDnet

1Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, Paediatric Gastroenterology, London, UK, 2Erasmus MC, Sophia Children's Hospital, Paediatric Gastroenterology, Rotterdam, The Netherlands, 3Université Paris Descartes, Sorbonne Paris Cité, APHP, Hopital Necker Enfants Malades, Department of Paediatric Gastroenterology, Paris, France

P786: The use and escalation of treatments in patients with inflammatory bowel disease; a 10 years follow-up of a Danish population-based inception cohortECCO '18 Vienna
Year: 2018
Authors:

B. Lo1*, I. Vind1, F. Bendtsen1, M. Vester-Andersen1,2, J. Burisch1

1Copenhagen University Hospital Hvidovre, The Gastro Unit, Medical Division, Hvidovre, Denmark, 2Zealand University Hospital, Medical Department, Køge, Denmark

P787: Impact of inflammatory bowel disease on working life: A French nationwide surveyECCO '18 Vienna
Year: 2018
Authors:

F. Gonzalez1,2*, A. Buisson3, A. Olympie3, M.-H. Ravel3, C. Bienenfeld4, L. Peyrin-Biroulet5

1Hepato-Gastroenterology, Nimes, France, 2CHU St Eloi, Montpellier, France, 3AFA, Paris, France, 4IFOP, Paris, France, 5CHRU Brabois, Nancy, France

P788: Significant medical and surgical morbidity in perianal Crohn’s disease: Results from a population-based studyECCO '18 Vienna
Year: 2018
Authors:

W.Y. Mak1*, O.S. Mak2, C.K. Lee3, W. Tang3, W.K. Leung4, M.K.K. Li5, F.H. Lo6, M.T. Wong7, A.S.F. Sze1, C.M. Leung8, S.W.C. Tsang9, E.H.S. Shan10, K.H. Chan11, B.C. Lam12, A.J. Hui13, W.H. Chow14, S.C. Ng3

1Queen Elizabeth Hospital, Medicine, Hong Kong, Hong Kong, 2The Chinese University of Hong Kong, Surgery, Hong Kong, Hong Kong, 3The Chinese University of Hong Kong, Medicine and Therapeutics, Hong Kong, Hong Kong, 4The University of Hong Kong, Medicine, Hong Kong, Hong Kong, 5Tuen Mun Hospital, Medicine and Geriatrics, Hong Kong, Hong Kong, 6United Christian Hospital, Medicine and Geriatrics, Hong Kong, Hong Kong, 7Princess Margaret Hospital, Medicine and Geriatrics, Hong Kong, Hong Kong, 8Pamela Youde Nethersole Eastern Hospital, Medicine, Hong Kong, Hong Kong, 9Tseung Kwan O Hospital, Medicine, Hong Kong, Hong Kong, 10Caritas Medical Centre, Medicine and Geriatrics, Hong Kong, Hong Kong, 11North District Hospital, Medicine, Hong Kong, Hong Kong, 12Kwong Wah Hospital, Medicine and Geriatrics, Hong Kong, Hong Kong, 13Alice Ho Miu Ling Nethersole Hospital, Medicine, Hong Kong, Hong Kong, 14Yan Chai Hospital, Medicine, Hong Kong, Hong Kong

P789: Incidence and survival of gastrointestinal cancer in patients with inflammatory bowel disease: A nationwide population-based study in KoreaECCO '18 Vienna
Year: 2018
Authors:

H.J. Kim1, J.J. Park2*, H.S. Ahn1

1College of Medicine, Korea University, Preventive Medicine, Seoul, South Korea, 2Gangnam Severance Hospital, Yonsei University College of Medicine, Internal Medicine, Seoul, South Korea